IPO Plus

515.4

+7.32 +1.44%

As of 22 Sept 2026 · delayed

NSE Listed · Pharmaceuticals

Jeena Sikho Lifecare Ltd. (JSLL)

Volume: 5,04,867Avg Vol 1W: 3,61,565Avg Vol 1M: 4,48,78952W Range:485.1849.5
Market Cap₹6,406 Cr
Current Price₹515.4
Previous Close₹508.08
High / Low (52w)₹849.5 / ₹485.1
Volume5,04,867
Avg Vol (1W)3,61,565
Avg Vol (1M)4,48,789
Stock P/E27.08
Book Value₹37.58
Dividend Yield87%
ROE47.5%
ROA35.05%
Revenue (TTM)
Revenue Growth39.71%
Profit Margin27.77%
Total Debt₹53,95,000 Cr
Shares Outstanding12 Cr
Face Value₹2
EPS (TTM)₹19.03
P/B13.72
Debt / Equity0.34
50 DMA₹535.21
200 DMA₹624.07
Day change+1.44%
Price Chart
515.4 37.02% · 1Y
8294782.3Cr
2025-09-22
2026-09-22

20-day avg volume: 4.5L shares

Pros
  • Healthy return on equity of 47.5%.
  • Pays a dividend yield of 87.0%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹114 Cr₹116 Cr₹139 Cr₹174 Cr₹190 Cr₹222 Cr₹216 Cr₹224 Cr
EBITDA₹37 Cr₹22 Cr₹37 Cr₹70 Cr₹83 Cr₹92 Cr₹65 Cr₹91 Cr
Net Profit₹27 Cr₹13 Cr₹25 Cr₹51 Cr₹59 Cr₹67 Cr₹45 Cr₹66 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹476 Cr₹139 Cr₹174 Cr₹190 Cr₹222 Cr₹216 Cr₹810 Cr₹224 Cr
EBITDA₹118 Cr₹37 Cr₹70 Cr₹83 Cr₹92 Cr₹65 Cr₹310 Cr₹91 Cr
Net Profit₹80 Cr₹25 Cr₹51 Cr₹59 Cr₹67 Cr₹45 Cr₹222 Cr₹66 Cr
EPS6.4317.84
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2025Mar 2026
Total Assets₹38 Cr₹49 Cr₹62 Cr₹151 Cr₹419 Cr₹674 Cr
Total Liabilities₹24 Cr₹25 Cr₹25 Cr₹25 Cr₹163 Cr₹207 Cr
Equity₹14 Cr₹24 Cr₹36 Cr₹126 Cr₹256 Cr₹467 Cr
Total Debt₹0 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2025Mar 2026
Operating₹21 Cr₹20 Cr₹23 Cr₹118 Cr₹327 Cr
Investing₹-8 Cr₹-18 Cr₹-33 Cr₹-64 Cr₹-202 Cr
Financing₹-2 Cr₹-5 Cr₹48 Cr₹-22 Cr₹-59 Cr
Free Cash Flow₹21 Cr₹15 Cr₹22 Cr₹118 Cr₹327 Cr
Shareholding
Promoter 63.62% Institutions 5.14% Public 31.24%
Efficiency & Working Capital
ROCE52.1%
Interest Coverage22.4
Dividend Payout
Debtor Days32 d
Inventory Days9 d
Payable Days11 d
Cash Conversion Cycle31 d
Working Capital Days41 d
Shareholding Details

As of 2026-06-30

Promoter63.6%
FII4.8%
DII0.4%
Institutions5.1%
Public31.2%
Promoter Pledge0%
No. of Shareholders43,413
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodNov 2023Nov 2023Mar 2024Sept 2024Mar 2025Jun 2025Aug 2025Aug 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters67.9%67.9%67.9%65.8%63.5%63.5%63.5%63.5%63.6%63.6%63.6%63.6%
FIIs1.8%1.8%0.3%4%6%5.9%6%6%6.6%6.3%6.2%4.8%
DIIs0%0%0%0%0%0%0.2%0.2%0.2%0.1%0.5%0.4%
Public30.3%30.3%31.8%30.1%30.5%30.6%30.3%30.3%29.7%30%29.8%31.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,1071,1072,7213,4235,9676,6037,4827,48216,36222,18125,90543,413
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Manish GroverShareholding of Promoter and Promoter Group63.3%7.86 Cr
Sixteenth Street Asian Gems FundPublic Shareholding4.2%52,19,863
Oregano Life Private LimitedPublic Shareholding3%36,67,913
Ajay Kumar AggarwalPublic Shareholding1.7%20,83,165
Bhavna GroverShareholding of Promoter and Promoter Group0.2%2,43,000
Rohit GroverShareholding of Promoter and Promoter Group0.1%76,191
Mukesh GroverShareholding of Promoter and Promoter Group0%52,740
Santosh GroverShareholding of Promoter and Promoter Group0%30,461
Sahil JainShareholding of Promoter and Promoter Group0%17,191
Shreya GroverShareholding of Promoter and Promoter Group0%8,190
Akansha JainShareholding of Promoter and Promoter Group0%8,190
Ashish GroverShareholding of Promoter and Promoter Group0%3,495
Madhav GroverShareholding of Promoter and Promoter Group0%0
Sunil KhuranaShareholding of Promoter and Promoter Group0%0
Som KhuranaShareholding of Promoter and Promoter Group0%0
Premkanta KapoorShareholding of Promoter and Promoter Group0%0
Sunita UppalShareholding of Promoter and Promoter Group0%0
Manish Grover (huf)Shareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Manish GroverChairman & Managing Director2025
Bhavna GroverWTD & Executive Director2025
Karan Vir BindraIndependent Non Exe. Director2025
Shreya GroverWhole-time Director2025
Chandan Kumar KaushalIndependent Non Exe. Director2025
Priyanka BansalIndependent Non Exe. Director2025
Smita ChaturvediCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Trading of Ayurvedic Medicines and₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2252525
Corporate Actions
TypeDateValueRemark
dividend2026-09-21₹4.5 (225%)Final
forthcoming2026-09-21Dividend
forthcoming2026-08-07Board Meetings
dividend2025-09-22₹1.1 (55%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500014722
202500010010
2025000405
Company Information
Incorporated2017
ChairmanManish Grover
AuditorKRA & Co/Walker Chandiok & Co LLP
Investor Email[email protected]
🌐 jeenasikho.com

📍 SCO 11 First Floor Kalgidhar, Enclave Zirakpur, Mohali, Punjab, 140604

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App